Correlation Between Salesforce and Bio Techne

Can any of the company-specific risk be diversified away by investing in both Salesforce and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and Bio Techne Corp, you can compare the effects of market volatilities on Salesforce and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Bio Techne.

Diversification Opportunities for Salesforce and Bio Techne

0.85

Correlation Coefficient

Salesforce  Bio Techne

Very poor diversification

The 3 months correlation between Salesforce and Bio is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Bio Techne Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne Corp and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne Corp has no effect on the direction of Salesforce i.e., Salesforce and Bio Techne go up and down completely randomly.

Pair Corralation between Salesforce and Bio Techne

Considering the 90-day investment horizon Salesforce is expected to generate 0.88 times more return on investment than Bio Techne. However, Salesforce is 1.14 times less risky than Bio Techne. It trades about -0.16 of its potential returns per unit of risk. Bio Techne Corp is currently generating about -0.15 per unit of risk. If you would invest  34,172  in Salesforce on December 25, 2024 and sell it today you would lose (5,576) from holding Salesforce or give up 16.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.33%
Values	Daily Returns

Salesforce  vs.  Bio Techne Corp

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bio Techne Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bio Techne Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Salesforce and Bio Techne

The main advantage of trading using opposite Salesforce and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.

The idea behind Salesforce and Bio Techne Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.